1002 related articles for article (PubMed ID: 22169620)
1. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
[TBL] [Abstract][Full Text] [Related]
2. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
Aoun M; Makki M; Azar H; Matta H; Chelala DN
BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
Mansour AG; Hariri E; Daaboul Y; Korjian S; El Alam A; Protogerou AD; Kilany H; Karam A; Stephan A; Bahous SA
J Am Soc Hypertens; 2017 Sep; 11(9):589-597. PubMed ID: 28756183
[TBL] [Abstract][Full Text] [Related]
4. Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients.
Dahlberg S; Ede J; Schurgers L; Vermeer C; Kander T; Klarin B; Schött U
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303985
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K intake and status are low in hemodialysis patients.
Cranenburg EC; Schurgers LJ; Uiterwijk HH; Beulens JW; Dalmeijer GW; Westerhuis R; Magdeleyns EJ; Herfs M; Vermeer C; Laverman GD
Kidney Int; 2012 Sep; 82(5):605-10. PubMed ID: 22648294
[TBL] [Abstract][Full Text] [Related]
6. The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial.
Oikonomaki T; Papasotiriou M; Ntrinias T; Kalogeropoulou C; Zabakis P; Kalavrizioti D; Papadakis I; Goumenos DS; Papachristou E
Int Urol Nephrol; 2019 Nov; 51(11):2037-2044. PubMed ID: 31529295
[TBL] [Abstract][Full Text] [Related]
7. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk.
Rapp N; Brandenburg VM; Kaesler N; Bakker SJL; Stöhr R; Schuh A; Evenepoel P; Schurgers LJ
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684491
[TBL] [Abstract][Full Text] [Related]
8. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.
Schlieper G; Westenfeld R; Krüger T; Cranenburg EC; Magdeleyns EJ; Brandenburg VM; Djuric Z; Damjanovic T; Ketteler M; Vermeer C; Dimkovic N; Floege J; Schurgers LJ
J Am Soc Nephrol; 2011 Feb; 22(2):387-95. PubMed ID: 21289218
[TBL] [Abstract][Full Text] [Related]
9. Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland.
Wyskida K; Żak-Gołąb A; Wajda J; Klein D; Witkowicz J; Ficek R; Rotkegel S; Spiechowicz U; Kocemba Dyczek J; Ciepał J; Olszanecka-Glinianowicz M; Więcek A; Chudek J
Int Urol Nephrol; 2016 May; 48(5):765-71. PubMed ID: 27000106
[TBL] [Abstract][Full Text] [Related]
10. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M
Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.
Caluwé R; Vandecasteele S; Van Vlem B; Vermeer C; De Vriese AS
Nephrol Dial Transplant; 2014 Jul; 29(7):1385-90. PubMed ID: 24285428
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
Strople J; Lovell G; Heubi J
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal vitamin K status and its risk factors in a population of Chinese chronic haemodialysis patients.
Feng Y; Ruan Y; He Q; Zhang W; Wang L
Nephrology (Carlton); 2015 Sep; 20(9):625-31. PubMed ID: 25917879
[TBL] [Abstract][Full Text] [Related]
14. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein.
Dalmeijer GW; van der Schouw YT; Magdeleyns E; Ahmed N; Vermeer C; Beulens JW
Atherosclerosis; 2012 Dec; 225(2):397-402. PubMed ID: 23062766
[TBL] [Abstract][Full Text] [Related]
15. Vitamin K status in healthy volunteers.
Theuwissen E; Magdeleyns EJ; Braam LA; Teunissen KJ; Knapen MH; Binnekamp IA; van Summeren MJ; Vermeer C
Food Funct; 2014 Feb; 5(2):229-34. PubMed ID: 24296867
[TBL] [Abstract][Full Text] [Related]
16. Role of Vitamin K in CKD: Is Its Supplementation Advisable in CKD Patients?
Grzejszczak P; Kurnatowska I
Kidney Blood Press Res; 2021; 46(5):523-530. PubMed ID: 34247173
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K status and mortality after kidney transplantation: a cohort study.
Keyzer CA; Vermeer C; Joosten MM; Knapen MH; Drummen NE; Navis G; Bakker SJ; de Borst MH
Am J Kidney Dis; 2015 Mar; 65(3):474-83. PubMed ID: 25453995
[TBL] [Abstract][Full Text] [Related]
18. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
[TBL] [Abstract][Full Text] [Related]
19. Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial.
Haroon SW; Tai BC; Ling LH; Teo L; Davenport A; Schurgers L; Teo BW; Khatri P; Ong CC; Low S; Yeo XE; Tan JN; Subramanian S; Chua HR; Tan SY; Wong WK; Lau TW
Medicine (Baltimore); 2020 Sep; 99(36):e21906. PubMed ID: 32899022
[TBL] [Abstract][Full Text] [Related]
20. The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification.
Cranenburg EC; Vermeer C; Koos R; Boumans ML; Hackeng TM; Bouwman FG; Kwaijtaal M; Brandenburg VM; Ketteler M; Schurgers LJ
J Vasc Res; 2008; 45(5):427-36. PubMed ID: 18401181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
